• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三氧化二砷通过去甲基化激活的 microRNA-491 抑制人肝癌细胞的侵袭潜能。

Arsenic trioxide attenuates the invasion potential of human liver cancer cells through the demethylation-activated microRNA-491.

机构信息

Key Laboratory of Modern Toxicology, Ministry of Education, Department of Nutrition and Food Hygiene, School of Public Health, Nanjing Medical University, Nanjing 211166, PR China.

Key Laboratory of Modern Toxicology, Ministry of Education, Department of Nutrition and Food Hygiene, School of Public Health, Nanjing Medical University, Nanjing 211166, PR China.

出版信息

Toxicol Lett. 2014 Jun 5;227(2):75-83. doi: 10.1016/j.toxlet.2014.03.016. Epub 2014 Mar 27.

DOI:10.1016/j.toxlet.2014.03.016
PMID:24680928
Abstract

Hepatocellular carcinoma (HCC) represents the third leading cause of cancer-related mortality worldwide. Current standard practices for treatment of HCC are less than satisfactory because of metastasis and recurrence. In addition to treating acute promyelocytic leukemia (APL), arsenic trioxide (As2O3) also suppresses other solid tumors, such as HCC. However, the effects of As2O3 on the migration/invasion potential of liver cancer cells and the molecular mechanisms underlying in remain unclear. Here we found that As2O3 attenuated the migration/invasion potential of HCC cell lines by blocking matrix metalloproteinases (MMPs) activities and inducing a mesenchymal to epithelial transition (MET). Indeed, As2O3 elevated the expression of microRNA-491 (miR-491) via demethylation. On one hand, as a target miRNA of MMP9, miR-491 decreased the MMP9 expression. On the other hand, miR-491 blocked the activation of nuclear factor κB (NF-κB), which transcriptionally inactivated MMP2 and induced a MET (as determined by the increased expression of E-cadherin and decreased expressions of snail, slug, and vimentin). Knockdown of miR-491 abolished the As2O3-induced MMPs inactivation, MET, and the migration/invasion potential of HCC cell lines. By understanding a novel mechanism how As2O3 inhibits the migration/invasion potential of liver cancer cells, our study may help to identify potential therapeutic targets for liver cancer.

摘要

肝细胞癌(HCC)是全球癌症相关死亡的第三大主要原因。由于转移和复发,目前 HCC 的治疗标准实践效果并不理想。三氧化二砷(As2O3)除了治疗急性早幼粒细胞白血病(APL)外,还能抑制其他实体肿瘤,如 HCC。然而,As2O3 对肝癌细胞迁移/侵袭潜力的影响及其潜在的分子机制尚不清楚。在这里,我们发现 As2O3 通过阻断基质金属蛋白酶(MMPs)的活性并诱导间质-上皮转化(MET)来减弱 HCC 细胞系的迁移/侵袭潜力。事实上,As2O3 通过去甲基化来提高 microRNA-491(miR-491)的表达。一方面,miR-491 作为 MMP9 的靶 miRNA,降低了 MMP9 的表达。另一方面,miR-491 阻断了核因子 κB(NF-κB)的激活,NF-κB 转录失活 MMP2 并诱导 MET(通过增加 E-钙粘蛋白的表达和降低 snail、slug 和波形蛋白的表达来确定)。miR-491 的敲低消除了 As2O3 诱导的 MMPs 失活、MET 和 HCC 细胞系的迁移/侵袭潜力。通过了解 As2O3 抑制肝癌细胞迁移/侵袭潜力的新机制,我们的研究可能有助于确定肝癌的潜在治疗靶点。

相似文献

1
Arsenic trioxide attenuates the invasion potential of human liver cancer cells through the demethylation-activated microRNA-491.三氧化二砷通过去甲基化激活的 microRNA-491 抑制人肝癌细胞的侵袭潜能。
Toxicol Lett. 2014 Jun 5;227(2):75-83. doi: 10.1016/j.toxlet.2014.03.016. Epub 2014 Mar 27.
2
Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells.微小RNA-491对TGF-β/SMAD3/NF-κB信号通路的抑制作用参与了三氧化二砷诱导的肝癌细胞抗血管生成过程。
Toxicol Lett. 2014 Nov 18;231(1):55-61. doi: 10.1016/j.toxlet.2014.08.024. Epub 2014 Sep 6.
3
Induction of the mesenchymal to epithelial transition by demethylation- activated microRNA-200c is involved in the anti-migration/invasion effects of arsenic trioxide on human breast cancer cells.去甲基化激活的微小RNA-200c诱导间充质向上皮转化参与三氧化二砷对人乳腺癌细胞的抗迁移/侵袭作用。
Mol Carcinog. 2015 Sep;54(9):859-69. doi: 10.1002/mc.22157. Epub 2014 Apr 14.
4
Inhibition of the cancer stem cells-like properties by arsenic trioxide, involved in the attenuation of endogenous transforming growth factor beta signal.三氧化二砷对癌症干细胞样特性的抑制作用,涉及内源性转化生长因子β信号的减弱。
Toxicol Sci. 2015 Jan;143(1):156-64. doi: 10.1093/toxsci/kfu218. Epub 2014 Oct 10.
5
MiR-491 attenuates cancer stem cells-like properties of hepatocellular carcinoma by inhibition of GIT-1/NF-κB-mediated EMT.微小RNA-491通过抑制GIT-1/核因子κB介导的上皮-间质转化来减弱肝癌的癌症干细胞样特性。
Tumour Biol. 2016 Jan;37(1):201-9. doi: 10.1007/s13277-015-3687-5. Epub 2015 Jul 19.
6
Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression.由核因子κB转录上调的微小RNA-143通过抑制纤连蛋白表达增强肝癌转移。
Hepatology. 2009 Aug;50(2):490-9. doi: 10.1002/hep.23008.
7
Synergistic antitumor activity of oridonin and arsenic trioxide on hepatocellular carcinoma cells.冬凌草甲素与三氧化二砷联合对肝癌细胞的协同抗肿瘤作用。
Int J Oncol. 2012 Jan;40(1):139-47. doi: 10.3892/ijo.2011.1210. Epub 2011 Sep 22.
8
Arsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen species.三氧化二砷(As2O3)抑制HT1080人纤维肉瘤细胞的侵袭:核因子-κB和活性氧的作用。
J Cell Biochem. 2005 Aug 1;95(5):955-69. doi: 10.1002/jcb.20452.
9
Induction of the mesenchymal to epithelial transition by demethylation-activated microRNA-125b is involved in the anti-migration/invasion effects of arsenic trioxide on human chondrosarcoma.去甲基化激活的微小RNA-125b诱导间充质向上皮转化参与三氧化二砷对人软骨肉瘤的抗迁移/侵袭作用。
J Exp Clin Cancer Res. 2016 Aug 30;35(1):129. doi: 10.1186/s13046-016-0407-y.
10
microRNA-539 suppresses tumor growth and tumorigenesis and overcomes arsenic trioxide resistance in hepatocellular carcinoma.微小RNA-539抑制肝癌的肿瘤生长和肿瘤发生,并克服三氧化二砷耐药性。
Life Sci. 2016 Dec 1;166:34-40. doi: 10.1016/j.lfs.2016.10.002. Epub 2016 Oct 4.

引用本文的文献

1
MicroRNA as Key Players in Hepatocellular Carcinoma: Insights into Their Role in Metastasis.微小RNA作为肝细胞癌的关键因素:对其在转移中作用的见解
Biochem Genet. 2025 Apr;63(2):1014-1062. doi: 10.1007/s10528-024-10897-0. Epub 2024 Aug 5.
2
Arsenic Trioxide Suppresses Angiogenesis in Non-small Cell Lung Cancer the Nrf2-IL-33 Signaling Pathway.三氧化二砷抑制非小细胞肺癌血管生成——Nrf2-IL-33 信号通路。
Anticancer Agents Med Chem. 2024;24(15):1142-1150. doi: 10.2174/0118715206288348240420174853.
3
MicroRNA-Gene Interactions Impacted by Toxic Metal(oid)s during EMT and Carcinogenesis.
在上皮-间质转化和致癌过程中受有毒金属(类金属)影响的微小RNA-基因相互作用
Cancers (Basel). 2022 Nov 25;14(23):5818. doi: 10.3390/cancers14235818.
4
Resveratrol Alleviates 27-Hydroxycholesterol-Induced Senescence in Nerve Cells and Affects Zebrafish Locomotor Behavior via Activation of SIRT1-Mediated STAT3 Signaling.白藜芦醇通过激活 SIRT1 介导的 STAT3 信号通路缓解 27-羟胆固醇诱导的神经细胞衰老,并影响斑马鱼的运动行为。
Oxid Med Cell Longev. 2021 Jun 21;2021:6673343. doi: 10.1155/2021/6673343. eCollection 2021.
5
Arsenic trioxide enhances the chemotherapeutic efficiency of cisplatin in cholangiocarcinoma cells via inhibiting the 14-3-3ε-mediated survival mechanism.三氧化二砷通过抑制14-3-3ε介导的生存机制提高顺铂在胆管癌细胞中的化疗效率。
Cell Death Discov. 2020 Sep 21;6(1):92. doi: 10.1038/s41420-020-00330-x. eCollection 2020.
6
Serum Proteomic Profiling Analysis of Rats Chronically Exposed to Arsenic.砷慢性暴露大鼠血清蛋白质组学分析
Med Sci Monit. 2019 Dec 24;25:9923-9932. doi: 10.12659/MSM.918696.
7
Targeting E-cadherin expression with small molecules for digestive cancer treatment.用小分子靶向E-钙黏蛋白表达以治疗消化系统癌症
Am J Transl Res. 2019 Jul 15;11(7):3932-3944. eCollection 2019.
8
Reversal of sorafenib resistance in hepatocellular carcinoma: epigenetically regulated disruption of 14-3-3η/hypoxia-inducible factor-1α.肝细胞癌中索拉非尼耐药性的逆转:14-3-3η/缺氧诱导因子-1α的表观遗传调控破坏
Cell Death Discov. 2019 Jul 19;5:120. doi: 10.1038/s41420-019-0200-8. eCollection 2019.
9
Traditional Chinese medicine-combination therapies utilizing nanotechnology-based targeted delivery systems: a new strategy for antitumor treatment.中药-联合疗法利用基于纳米技术的靶向递药系统:抗肿瘤治疗的新策略。
Int J Nanomedicine. 2019 Mar 22;14:2029-2053. doi: 10.2147/IJN.S197889. eCollection 2019.
10
Arsenic trioxide reverses the chemoresistance in hepatocellular carcinoma: a targeted intervention of 14-3-3η/NF-κB feedback loop.三氧化二砷逆转肝癌的化疗耐药性:14-3-3η/NF-κB 反馈环的靶向干预。
J Exp Clin Cancer Res. 2018 Dec 20;37(1):321. doi: 10.1186/s13046-018-1005-y.